|
Qualitätsindikator
3: Hormonrezeptoranalyse |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualitätsziel: |
|
|
Möglichst viele Patientinnen mit
immunhistochemischer Hormonrezeptoranalyse |
|
|
|
|
|
|
|
|
|
|
|
|
bei invasivem Mammakarzinom |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grundgesamtheit: |
|
Alle Patientinnen mit führendem
histologischen Befund „invasives Mammakarzinom” |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Referenzbereich: |
|
>= 95% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gesamt 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anzahl |
|
|
|
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alle Patientinnen mit
immunhisto- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
chemischer
Hormonrezeptoranalyse |
|
|
|
|
|
|
|
|
|
61.147 / 63.814 |
|
|
95,82% |
|
|
|
Vertrauensbereich |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95,66% - 95,97% |
|
|
|
Referenzbereich |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
>= 95% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vorjahresdaten |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gesamt 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anzahl |
|
|
|
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alle Patientinnen mit
immunhisto- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
chemischer
Hormonrezeptoranalyse |
|
|
|
|
|
|
|
|
|
56.951 / 59.873 |
|
|
95,12% |
|
|
|
Vertrauensbereich |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
94,94% - 95,29% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Verteilung der Krankenhausergebnisse
[Diagramm 3]: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anteil von Patientinnen mit
immunhistochemischer Hormonrezeptoranalyse an allen Patientinnen |
|
|
|
|
|
mit invasivem Mammakarzinom |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
81 Krankenhäuser haben keinen Fall in dieser
Grundgesamtheit. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Krankenhäuser mit mindestens 20 Fällen in
dieser Grundgesamtheit: |
|
|
|
|
|
|
|
|
|
|
|
|
Minimum - Maximum der Krankenhausergebnisse:
0,0% - 100,0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Median der Krankenhausergebnisse: 97,4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
665 Krankenhäuser haben mindestens 20 Fälle
in dieser Grundgesamtheit. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Krankenhäuser mit weniger als 20 Fällen in
dieser Grundgesamtheit: |
|
|
|
|
|
|
|
|
|
|
|
|
Minimum - Maximum der Krankenhausergebnisse:
0,0% - 100,0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Median der Krankenhausergebnisse: 100,0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
372 Krankenhäuser haben weniger als 20 Fälle
in dieser Grundgesamtheit. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outcome 2004
Qualitätsreport 2003